Eyenovia Inc Pipeline Update Conference Call Transcript
Ladies and gentlemen, thank you for standing by. Welcome to the Eyenovia Pipeline Update Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to hand the conference over to your speaker today, Tram Bui from The Ruth Group.
Good afternoon and welcome to Eyenovia's conference call and audio webcast. With me today are Dr. Sean Ianchulev, Eyenovia's Chief Executive Officer and Chief Medical Officer; John Gandolfo, Eyenovia's Chief Financial Officer; and Michael Rowe, Eyenovia's Vice President of Commercial.
Earlier this afternoon, Eyenovia issued a press release announcing the advancement of its micro line program for the treatment of presbyopia for Phase III development and the reprioritization of its late-stage ophthalmology pipeline. We encourage everyone to read today's press release as well as the supplementary materials Eyenovia filed with the SEC.
In addition, this conference call is being webcast through
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |